Literature DB >> 10487486

Cysteine is a cardiovascular risk factor in hyperlipidemic patients.

N Jacob1, E Bruckert, P Giral, M J Foglietti, G Turpin.   

Abstract

Several studies have reported that moderate hyperhomocysteinemia is related to an increased risk for atherosclerosis, but few data are available with regard to any other thiol compound having a potential vascular toxicity. Therefore, we measured both total cysteine and homocysteine plasma levels in patients with hyperlipidemia (242 males and 147 females, 41-65 years old). Homocysteine was higher in males than in females, 13.2+/-4.1 versus 11.1+/-3.4 micromol/l (P<0.0001). The mean cysteine level was 243.3+/-45.7 micromol/l in the whole study population. The subjects were split in two groups, symptomatic patients with cardiovascular disease (n = 106) and asymptomatic subjects (n = 283). Blood pressure, smoking status, total cholesterol, LDL-cholesterol and triglycerides did not statistically differ between groups, but the mean HDL-cholesterol level was lower in symptomatic patients (1.24+/-0.38 versus 1.42+/-0.41, P<0.0001). Cysteine levels were higher in patients with cardiovascular disease than in asymptomatic patients, respectively 254.7+/-47.7 versus 239.1+/-44.3 micromol/l (P = 0.003). A similar result was found for homocysteine, respectively 13.1+/-4.3 versus 12.2+/-3.9 micromol/l (P = 0.05). To analyse whether cysteine levels were related to atherosclerosis independently of age, adjusted levels were compared between asymptomatic patients with normal carotid arteries (n = 176), carotid atherosclerosis (n = 107) and symptomatic patients (n = 106). Age adjusted cysteine levels differed significantly between groups (P = 0.027) while the P-value was of borderline significance for homocysteine (P = 0.09). Odds ratios for having symptomatic cardiovascular disease were 1.81 (95% CI, 1.02-3.21) and 2.05 (95% CI, 1.16-3.60) for the mid and highest tertiles of cysteine using the lowest as the reference. After adjustment in a multivariate model including age, sex, and creatinine, the odds ratio for disease remained significant between the highest tertile versus the lowest (OR = 1.89). Adjusted odds ratios were found to be weaker when homocysteine tertiles were compared. Our data suggest that plasma total cysteine is a risk factor for atherosclerosis in hyperlipidemic patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487486     DOI: 10.1016/s0021-9150(99)00128-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  17 in total

Review 1.  Oxidative stress and ageing: is ageing a cysteine deficiency syndrome?

Authors:  Wulf Dröge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

2.  Effect of five cysteine-containing compounds on three lipogenic enzymes in Balb/cA mice consuming a high saturated fat diet.

Authors:  Chun-che Lin; Mei-chin Yin; Cheng-chin Hsu; Meng-pei Lin
Journal:  Lipids       Date:  2004-09       Impact factor: 1.880

Review 3.  Cysteine/cystine redox signaling in cardiovascular disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2010-12-03       Impact factor: 7.376

4.  Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield.

Authors:  Timothy A Larson; Pratixa P Joshi; Konstantin Sokolov
Journal:  ACS Nano       Date:  2012-09-25       Impact factor: 15.881

5.  The effects of L-cysteine and N-acetyl-L-cysteine on homocysteine metabolism and haemostatic markers, and on cardiac and aortic histology in subchronically methionine-treated Wistar male rats.

Authors:  Sanja Kostić; Žarko Mićovic; Lazar Andrejević; Saša Cvetković; Aleksandra Stamenković; Sanja Stanković; Radmila Obrenović; Milica Labudović-Borović; Dragan Hrnčić; Vladimir Jakovljević; Dragan Djurić
Journal:  Mol Cell Biochem       Date:  2018-06-23       Impact factor: 3.396

6.  Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects.

Authors:  Yunjun Xiao; Yuan Zhang; Xiaofei Lv; Dongfang Su; Dan Li; Min Xia; Jian Qiu; Wenhua Ling; Jing Ma
Journal:  Lipids Health Dis       Date:  2011-08-12       Impact factor: 3.876

7.  Plasma total cysteine and cardiovascular risk burden: action and interaction.

Authors:  Benedetta De Chiara; Valentina Sedda; Marina Parolini; Jonica Campolo; Renata De Maria; Raffaele Caruso; Gianluigi Pizzi; Olga Disoteo; Cinzia Dellanoce; Anna Rosa Corno; Giuliana Cighetti; Oberdan Parodi
Journal:  ScientificWorldJournal       Date:  2012-04-19

Review 8.  Mass Spectrometry in Advancement of Redox Precision Medicine.

Authors:  Xiaofei Chen; Jingyun Lee; Hanzhi Wu; Allen W Tsang; Cristina M Furdui
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 3.650

9.  ¹H-NMR and MS based metabolomics study of the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet.

Authors:  Ze-Yun Li; Li-Li Ding; Jin-Mei Li; Bao-Li Xu; Li Yang; Kai-Shun Bi; Zheng-Tao Wang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

10.  Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload.

Authors:  Kristýna Pimková; Leona Chrastinová; Jiří Suttnar; Jana Štikarová; Roman Kotlín; Jaroslav Čermák; Jan Evangelista Dyr
Journal:  Oxid Med Cell Longev       Date:  2014-01-14       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.